← Leaderboards
Gretchen Gierach
Division Of Cancer Epidemiology And Genetics
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Cancer Epidemiology And Genetics
Same institution · by research overlap
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsHormonesBreast Cancer Risk FactorCohortEstrogensCollaborationsCancer RiskMalignant Breast NeoplasmMalignant Neoplasm Of OvaryEtiologyMalignant Neoplasm Of Cervix UteriWomanRisk FactorsHormonalIncidenceLinkMothersMalignant Neoplasm Of ProstateMultidisciplinaryGeneticDesignInterestMetabolicAndrogens
Grant awards (24)
Hormone-Related Cancers$7,798,281
ZIA · FY2025 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$221,789
ZIA · FY2025 · CA · contact PI
Nutrition, Metabolism, and Cancer$127,581
ZIA · FY2025 · CA · contact PI
Therapeutic and Diagnostic Factors as Related to Cancer Risk$53,627
ZIA · FY2025 · CA · contact PI
Hormone-Related Cancers$7,540,188
ZIA · FY2024 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$565,112
ZIA · FY2024 · CA · contact PI
Therapeutic and Diagnostic Factors as Related to Cancer Risk$224,821
ZIA · FY2024 · CA · contact PI
Nutrition, Metabolism, and Cancer$158,624
ZIA · FY2024 · CA · contact PI
Hormone-Related Cancers$8,450,375
ZIA · FY2023 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$1,028,736
ZIA · FY2023 · CA · contact PI
Nutrition, Metabolism, and Cancer$258,316
ZIA · FY2023 · CA · contact PI
Therapeutic and Diagnostic Factors as Related to Cancer Risk$240,155
ZIA · FY2023 · CA · contact PI
Hormone-Related Cancers$9,342,840
ZIA · FY2022 · CA · contact PI
Therapeutic and Diagnostic Factors as Related to Cancer Risk$313,017
ZIA · FY2022 · CA · contact PI
Nutrition, Metabolism, and Cancer$282,826
ZIA · FY2022 · CA · contact PI
Hormone-Related Cancers$10,082,372
ZIA · FY2021 · CA · contact PI
Therapeutic and Diagnostic Factors as Related to Cancer Risk$240,061
ZIA · FY2021 · CA · contact PI
Nutrition, Metabolism, and Cancer$174,379
ZIA · FY2021 · CA · contact PI
Endogenous Hormone Measurement Production Assay Infrastructure at the FNLCR$88,164
ZIC · FY2021 · CA · contact PI
Hormone-Related Cancers$11,426,422
ZIA · FY2020 · CA · contact PI
Nutrition, Metabolism, and Cancer$317,441
ZIA · FY2020 · CA · contact PI
Hormone-Related Cancers$8,421,316
ZIA · FY2019 · CA · contact PI
Hormone-Related Cancers$2,799,580
ZIA · FY2018 · CA · contact PI
Hormone-Related Cancers$3,383,977
ZIA · FY2017 · CA · contact PI